[Pre-market performance]
Tonghuashun (300033) US stock News As of press time, the Dow Jones Industrial Average futures , mainly blue chip stock , fell 0.33%; the S&P 500 index futures fell 0.56%; the Nasdaq 100 index futures, mainly technology stock , fell 1.04%.
Popular Chinese stocks listed in the United States fell before the market trading.
European stock markets fell. As of press time, German DAX index fell 1.46%; French CAC40 index fell 1.36%; and FTSE 100 index fell 0.76%. In terms of commodity foreign exchange, as of press time, Brent crude oil rose 0.03% to US$86.30 per barrel.
[Financial News]
The US 30-year mortgage interest rate exceeded 7%
Federal Reserve Radical Rate hike As the US mortgage interest rate is soaring at the fastest pace in history, and the US real estate market is cooling down at a record speed. A daily survey by Mortgage News Daily shows that the average interest rate for 30-year mortgage loans in the United States continued to soar after rising above 6%, hitting 7.08% on September 27, the highest level since December 11, 2000. This also means that the interest rate rose by nearly 1 percentage point in less than two weeks, setting the fastest rise in history.
[Company News]
OcugenU.S. stocks rose more than 9% before the market opened
Ocugen rose more than 9% before the market opened, and previously announced an agreement with the University of Washington on the commercialization of the nasal spraying new coronavirus vaccine in the United States, Europe and Japan.
QuToutiao received Nasdaq does not meet the minimum stock price requirements
QuToutiao received a Nasdaq notification on September 26, 2022, saying that it does not meet the minimum stock price requirements. The closing price of the company's American depositary receipt has been below the minimum share price requirement of $1.00 per share for the past 30 consecutive trading days.
Monster Charging announced that the equity repurchase plan will be extended by 12 months
On September 28, Monster Charging issued an announcement announcing that the board of directors has approved the extension of the implementation period of the equity repurchase plan to September 27, 2023. Monster Charging launched a 12-month equity repurchase program on September 28, 2021, under which the company can repurchase American depositary shares (ADS) with a total value of no more than $50 million.
rumor Toyota launches a small electric sedan bZ3 in China by the end of the year, with a price of about 200,000 yuan
It is reported that Toyota plans to start producing and selling a small electric sedan loading with BYD (002594) batteries by the end of the year, which is part of Toyota and BYD's continued cooperation. This bZ3 sedan, which is only for the Chinese market, will be the second model in Toyota's new Beyond Zero (bZ) pure electric vehicle series.
ExxonMobil and Shell start selling oil and gas assets of the UK and Dutch
Energy giants ExxonMobil and Shell have hired financial institutions Jefferies ( Jefferies) to start selling a large number of offshore gas assets in the UK and the Netherlands. If the sale is successful, it may raise more than $2 billion.
Harley-Davidson merged its electric motorcycle division with SPAC 5 for nearly 1.8 billion
On Tuesday local time, Harley-Davidson's electric motorcycle division LiveWire merged with (SPAC) for 1.77 billion special purpose acquisition company called AEA-Bridges Impact, becoming the first publicly listed electric motorcycle company in the United States with the stock code "LVWR".
Lyft suspends U.S. recruitment activities until the end of the year
U.S. ride-hailing company Lyft said that due to the instability of the economic situation, the company will freeze all recruitment activities in the United States by at least next year. "Like many companies, we will suspend recruitment activities for all U.S. jobs by the end of this year," a spokesperson for the company said in a statement. "Lisai raised its target price from $207 to $270 after the company and its partner Eisai announced good data on its Phase 3 trial of lecanemab, a targeted drug for Alzheimer's disease.
Beauty Health: D.A. Davidson raised its target price from $30 to $31 after the company announced a stock buyback authorization of up to $200 million.
TD Synnex: JPMorgan Chase lowered its target price from $119 to $114 to take into account the adverse factors of the rise in exchange rate and interest expenses.
Teladoc Health: RBC lowered its target price from $53 to $35 due to increased risk of performance guidance.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-